Imperial College London survey suggests confidence in coronavirus vaccines is rising globally

A recent survey from the Imperial College London’s Institute of Global Health Innovation has shown that willingness to receive a COVID-19 vaccine is increasing.

The survey was initially run in November 2020 across 15 countries and demonstrated that just 41% of people would be willing to get vaccinated against COVID-19 at the time. This number has risen to 54% in results from the same survey, run again in January 2021. Results demonstrated vast differences in attitudes towards vaccination based on location, with 78% of people surveyed in the UK willing to be vaccinated with a COVID-19 vaccine. People in France demonstrated the least willingness, with 44% of people stating they would not be vaccinated.

The survey further demonstrated that worry over vaccine side effects has decreased in 9 of the 15 countries who participated. The report is part of a global effort to monitor health related behaviours and attitudes during the pandemic to inform decision-makers based on a country’s needs.

Read more about the results of the survey via the link below:

Imperial College London: Confidence in coronavirus vaccines is rising globally, survey suggests

ASCIA release COVID-19 vaccination position statement

The Australasian Society of Clinical Immunology and Allergy (ASCIA) have released a position statement on COVID-19 vaccination. The statement reflects the COVID-19 vaccines the Therapeutic Goods Administration (TGA) has granted provisional approval for use in Australia, as well as vaccines that may also be granted provisional approval in the future. It contains guidance based on current data for COVID-19 vaccination in people with allergic conditions, immunodeficiencies and autoimmune conditions, pregnant and breastfeeding women and children under 16 years of age.

You can access the full statement via the link below:

ASCIA: Allergy, Immunodeficiency, Autoimmunity and COVID-19 Vaccination Position Statement

Community pharmacies to participate in COVID-19 vaccination program

The Australian Government has announced an expression of interest (EOI) process has begun for community pharmacies to participate in the COVID-19 vaccination program.

Participation is voluntary, with pharmacies needing to demonstrate their capacity, capability and ability to meet high safety standards.

Eligible pharmacies would be able to deliver COVID-19 vaccines to priority populations from phase 2a of the of Australian COVID-19 vaccination rollout strategy (expected to be in May 2021). They would be incentivised to provide both doses of the AstraZeneca COVID-19 vaccine in an effort to increase uptake of the vaccine.

Read more about this in the Health Minister’s statement via the link below:

Community Pharmacy to join COVID-19 vaccine workforce